The consumption of low- and no-calorie sweeteners, long marketed as healthier alternatives to refined sugar, may be associated with a significantly faster rate of cognitive decline, according to a comprehensive study published in the September 3, 2025, issue of Neurology, the medical journal of the American Academy of Neurology. The research, which tracked nearly 13,000 adults over the course of eight years, suggests that individuals with the highest intake of these sugar substitutes experienced a decline in thinking and memory skills equivalent to several years of additional biological aging. While the study establishes a strong correlation between sweetener consumption and cognitive impairment, researchers noted that the findings do not yet prove a direct causal relationship, though the strength of the data has prompted calls for further investigation into the long-term neurological impacts of ultra-processed food additives.
Understanding the Link Between Sweeteners and Brain Health
As the global prevalence of metabolic disorders such as obesity and type 2 diabetes has risen, so too has the consumption of non-nutritive sweeteners. These substances—ranging from synthetic compounds like aspartame to sugar alcohols like erythritol—are ubiquitous in the modern diet, appearing in everything from diet sodas and flavored waters to yogurts and "guilt-free" desserts. However, the study led by Claudia Kimie Suemoto, MD, PhD, of the University of São Paulo in Brazil, suggests that the brain may pay a price for these calorie-saving substitutions.
The study followed 12,772 participants with an average age of 52. Over an eight-year period, researchers monitored the cognitive health of these individuals, focusing on key domains such as verbal fluency, working memory, word recall, and processing speed. The results were stark: those in the highest tier of sweetener consumption showed a 62% faster decline in overall cognitive function compared to those who consumed the least. In practical terms, the researchers calculated that this accelerated decline was equivalent to approximately 1.6 years of additional brain aging. Even moderate consumers were not immune; those in the middle consumption group experienced a 35% faster decline, equivalent to roughly 1.3 years of aging.
Methodology and Participant Profiles
The research utilized data from a large-scale cohort in Brazil, providing a robust cross-section of the adult population. At the beginning of the study, participants completed detailed dietary questionnaires that accounted for their intake of food and beverages over the previous 12 months. This allowed researchers to quantify the exact amount of various sweeteners being consumed.
Participants were divided into three distinct groups based on their daily intake:
- Low Consumption Group: Averaged approximately 20 milligrams per day (mg/day).
- Moderate Consumption Group: Represented the middle tier of intake.
- High Consumption Group: Averaged 191 mg/day.
To put these numbers into perspective, 191 mg of aspartame is roughly equivalent to the amount found in a single 12-ounce can of diet soda. The study also highlighted that sorbitol was the most heavily consumed sweetener among the participants, with an average intake of 64 mg/day. By conducting cognitive assessments at the start, middle, and end of the eight-year period, the researchers were able to map the trajectory of mental decline with high precision, adjusting for confounding variables such as age, sex, education, smoking status, and existing cardiovascular conditions like hypertension.
The Vulnerability of Different Demographics
One of the most significant findings of the study was the varying impact of sweeteners across different age groups and health profiles. Interestingly, the link between high sweetener intake and cognitive decline was most pronounced in participants under the age of 60. In this younger cohort, high consumption was specifically tied to faster declines in verbal fluency and overall cognition. In contrast, the researchers did not find a statistically significant link in participants over the age of 60, suggesting that middle age may be a critical window during which the brain is particularly susceptible to the effects of these additives.
Furthermore, the study identified a heightened risk for individuals living with diabetes. While the association between sweeteners and cognitive decline was present in the general population, it was significantly stronger among those with impaired glucose metabolism. "People with diabetes are more likely to use artificial sweeteners as sugar substitutes to manage their blood sugar levels," noted Dr. Suemoto. This creates a potential paradox where a tool used to manage one chronic condition may inadvertently accelerate the progression of another—cognitive impairment.
A Closer Look at Specific Sweeteners
The study examined seven specific low- and no-calorie sweeteners, finding that most were associated with negative cognitive outcomes. The list of substances linked to faster decline included:
- Aspartame: Commonly found in diet carbonated drinks and tabletop sweeteners.
- Saccharin: One of the oldest artificial sweeteners, often used in "pink packet" substitutes.
- Acesulfame-K: Frequently used in combination with other sweeteners in sodas and baked goods.
- Erythritol and Xylitol: Sugar alcohols often used in keto-friendly products and sugar-free gums.
- Sorbitol: A bulk sweetener used in many low-calorie candies and pharmaceutical products.
Of the substances tested, only tagatose showed no association with cognitive decline. Tagatose is a rare sugar that is naturally occurring in dairy products but is produced commercially for use as a sweetener. Unlike some synthetic alternatives, tagatose has a low glycemic index and may behave differently within the metabolic and neurological pathways, though researchers indicated that more specific studies are needed to understand why it remained an outlier in this data set.
Contextualizing the Results: The Ultra-Processed Food Factor
The findings of the Neurology study contribute to a growing body of evidence suggesting that ultra-processed foods (UPFs) have a detrimental effect on long-term health. Artificial sweeteners are a hallmark of UPFs, designed to mimic the palatability of sugar without the caloric load. However, recent nutritional science has begun to question the "free pass" given to these chemicals.
In 2023, the World Health Organization (WHO) issued a conditional recommendation against using non-sugar sweeteners (NSS) for weight control, citing potential long-term risks such as an increased risk of type 2 diabetes and cardiovascular diseases. The Brazilian study extends these concerns into the realm of neurology. Experts suggest that the mechanisms at play could involve the disruption of the gut-brain axis, alterations in the gut microbiome, or the triggering of low-grade systemic inflammation, all of which are known contributors to neurodegeneration.
Implications for Public Health and Consumer Choice
The results of this study present a challenge for public health officials and dietitians. For decades, the primary message to the public has been to reduce sugar intake to combat obesity and heart disease. This has led to a massive shift toward "diet" and "zero-sugar" products. If these substitutes are indeed linked to cognitive decline, the advice given to consumers may need to be refined.
Dr. Suemoto emphasized the need for exploring more natural alternatives. "More research is needed to confirm our findings and to investigate if other refined sugar alternatives, such as applesauce, honey, maple syrup, or coconut sugar, may be effective alternatives," she stated. While these alternatives do contain calories and impact blood sugar, they may lack the specific neurological "penalty" associated with synthetic or highly processed sugar alcohols.
Industry Reactions and Scientific Caution
While the medical community has received the study with interest, industry groups representing sweetener manufacturers often point to the long history of regulatory approval for these substances. Agencies like the FDA and EFSA (European Food Safety Authority) have maintained that sweeteners like aspartame are safe for human consumption within established daily limits.
However, critics of the current regulatory framework argue that safety assessments often focus on acute toxicity or cancer risk, rather than long-term "silent" effects like cognitive aging. The Neurology study is significant because it looks at "real-world" consumption over nearly a decade, providing a window into how these substances affect the human brain as it ages.
The study authors were careful to note its limitations. Because diet information was self-reported, there is a risk of recall bias—participants may not have accurately remembered every item they consumed. Additionally, while the study adjusted for many factors, it is possible that "high sweetener consumers" also engaged in other lifestyle behaviors that contributed to cognitive decline, which were not fully captured by the data.
The Path Forward for Neurological Research
The revelation that a single can of diet soda’s worth of aspartame could be linked to a 62% faster rate of cognitive decline is likely to spark a new wave of clinical trials. Future research will likely focus on the biological mechanisms—specifically how these chemicals cross the blood-brain barrier and whether they influence the accumulation of amyloid plaques or tau proteins associated with Alzheimer’s disease.
For now, the message for consumers is one of moderation. As the medical community shifts toward a more holistic view of "brain-healthy diets," the focus is increasingly moving away from simple calorie counting and toward the quality of ingredients. Reducing the reliance on ultra-processed sweeteners in favor of whole foods and natural flavors may be a vital step in preserving cognitive longevity in an aging global population.
The study was supported by a coalition of Brazilian scientific and governmental bodies, including the Brazilian Ministry of Health and the National Council for Scientific and Technological Development, highlighting the growing international concern regarding the intersection of industrial nutrition and public health.
